A spec play with a potential healthy boost

CNBC Videos
A spec play with a potential healthy boost
This week, three firms initiated coverage on speculative development stage biotech company Pharmacyclics. Mad Money host Jim Cramer reveals the risks with this spec play.
View Comments (0)